All change at Galen as profits double
Pharmaceutical company Galen has seen pre-tax profits double to $48m (€40.38m) in Q2 and directors are to recommend a name change to shareholders at year's end to Warner Chilcott PLC.
This reflects the Craigavon-based firm's now exclusive focus on the US market following the sale of its non-core businesses in the UK.





